Robbie Marcus
Stock Analyst at JP Morgan
(3.89)
# 649
Out of 5,055 analysts
173
Total ratings
55.65%
Success rate
8.17%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $90 → $100 | $95.87 | +4.31% | 12 | Nov 13, 2025 | |
| HTFL HeartFlow | Maintains: Overweight | $36 → $40 | $27.98 | +42.96% | 2 | Nov 13, 2025 | |
| CNMD CONMED | Maintains: Neutral | $58 → $52 | $42.04 | +23.69% | 8 | Nov 6, 2025 | |
| RXST RxSight | Maintains: Underweight | $8 → $9 | $9.73 | -7.50% | 6 | Nov 6, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $115 → $100 | $89.91 | +11.22% | 7 | Nov 6, 2025 | |
| CBLL CeriBell | Maintains: Overweight | $21 → $17 | $12.90 | +31.78% | 2 | Nov 5, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $110 → $82 | $86.35 | -5.04% | 7 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Neutral | $90 → $75 | $58.06 | +29.18% | 3 | Oct 31, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underweight | $12 → $13 | $11.77 | +10.45% | 7 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $85 → $90 | $86.30 | +4.29% | 6 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $16 | $15.60 | +2.56% | 3 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $76 → $66 | $72.13 | -8.50% | 6 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $12.94 | +23.65% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $15 → $7 | $9.27 | -24.49% | 6 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $120 | $85.09 | +41.03% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $18.47 | +94.91% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $445 | $362.22 | +22.85% | 9 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $549.51 | +22.84% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $7.36 | +76.63% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $102.69 | +7.12% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $332.70 | -0.81% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $32.90 | +21.58% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $73.15 | +23.03% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $29.99 | +66.72% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $3.03 | +164.03% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $280.07 | -10.74% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $6.90 | +1.45% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $130.59 | -9.64% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $170.82 | -8.68% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $90.03 | -55.57% | 2 | May 5, 2020 |
Medtronic
Nov 13, 2025
Maintains: Neutral
Price Target: $90 → $100
Current: $95.87
Upside: +4.31%
HeartFlow
Nov 13, 2025
Maintains: Overweight
Price Target: $36 → $40
Current: $27.98
Upside: +42.96%
CONMED
Nov 6, 2025
Maintains: Neutral
Price Target: $58 → $52
Current: $42.04
Upside: +23.69%
RxSight
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $9.73
Upside: -7.50%
Zimmer Biomet Holdings
Nov 6, 2025
Downgrades: Neutral
Price Target: $115 → $100
Current: $89.91
Upside: +11.22%
CeriBell
Nov 5, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $12.90
Upside: +31.78%
Inspire Medical Systems
Nov 4, 2025
Maintains: Neutral
Price Target: $110 → $82
Current: $86.35
Upside: -5.04%
DexCom
Oct 31, 2025
Maintains: Neutral
Price Target: $90 → $75
Current: $58.06
Upside: +29.18%
Integra LifeSciences Holdings
Oct 31, 2025
Maintains: Underweight
Price Target: $12 → $13
Current: $11.77
Upside: +10.45%
Edwards Lifesciences
Oct 31, 2025
Maintains: Neutral
Price Target: $85 → $90
Current: $86.30
Upside: +4.29%
Oct 30, 2025
Maintains: Neutral
Price Target: $13 → $16
Current: $15.60
Upside: +2.56%
Aug 28, 2025
Maintains: Neutral
Price Target: $76 → $66
Current: $72.13
Upside: -8.50%
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $12.94
Upside: +23.65%
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $9.27
Upside: -24.49%
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $85.09
Upside: +41.03%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $18.47
Upside: +94.91%
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $362.22
Upside: +22.85%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $549.51
Upside: +22.84%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $7.36
Upside: +76.63%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $102.69
Upside: +7.12%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $332.70
Upside: -0.81%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $32.90
Upside: +21.58%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $73.15
Upside: +23.03%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $29.99
Upside: +66.72%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $3.03
Upside: +164.03%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $280.07
Upside: -10.74%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $6.90
Upside: +1.45%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $130.59
Upside: -9.64%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $170.82
Upside: -8.68%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $90.03
Upside: -55.57%